Biotech Intellectual Property at the Crossroads – IP Think Tank podcast 18 May 2009

Welcome to this special edition of the IP Think Tank podcast for Monday the 18th of May 2009.  In this call Duncan speaks to Gregory Glover, a panellist at the 2009 BIO International Convention about the pending Biosimilar legislation and concerns over situations where a follow on product might avoid patent claims but still be able to rely on innovator regulatory data.

We hope you enjoy this show, and as always, we look forward to your comments and feedback.
[podcast]http://www.thinkipstrategy.com/wp-content/podcasts/20090518IPTTPodcastBIO.mp3[/podcast]
Links:
The 2009 BIO International Convention – http://convention.bio.org
The Panel session ‘Biotech Intellectual Property at the Crossroads’ – http://convention.bio.org/templates/default_page_template.aspx?id=1415

Gregory Glover – http://www.pharmalawgrp.com/biography.html

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 20,695 other followers

%d bloggers like this: